Blog Archives

Potenzielles Risiko von Herzrhythmusstörungen mit Fenspirid-haltigen Arzneimitteln

17. Februar 2019 – Fenspirid-haltige Arzneimittel scheinen ein potenzielles Risiko von Herzrhythmusstörungen zu beinhalten. Dies geht aus einem Beschluss des Ausschuss für Risikobewertung im Bereich der Pharmakovigilanz (PRAC) der European Medicines Agency (EMA) hervor, welcher eine Europa-weite Aussetzung von Fenspirid-haltigen Arzneimitteln empfohlen hat.

Read more ›

Tags: , , , , , , , , , , , ,

Ein Wort zu Valsartan, weiteren Sartanen, und deren Verunreinigungen

3. Februar 2019 – Blutdrucksenkende Arzneimittel welche die Wirkstoffe Valsartan, Candesartan, Irbesartan, Losartan, oder Olmesartan enthalten, sind in den vergangenen Monaten zunehmend in die Kritik geraten, da in verschiedensten Chargen dieser Arzneimittel nitrosaminhaltige Verunreinigungen wie N-Nitrosodimethylamin (NDMA) und N-Nitrosodiethylamin (NDEA), die von der WHO als wahrscheinliche menschliche Karzinogene eingestuft werden,

Read more ›

Tags: , , , , , , , , , , , ,

Alternative Fakten bei der Zulassung von Generika?

30. März 2017 – Alternative Fakten scheinen nicht nur in der neueren politischen Landschaft Verbreitung zu finden, wenn es darum geht, eigene Interessen durch Falschangaben durch zu setzen. Basierend auf der folgenden Meldung muss man davon ausgehen, dass alternative Fakten auch bei der Zulassung von Generika versuchsweise zum Zuge kommen,

Read more ›

Tags: , , , , , ,

thasso: zustände

thasso: neueste tweets

thasso: kürzliche kommentare

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

  • How hormone therapy slows progression of atherosclerosis September 28, 2020
    As one of the most common treatments for effectively managing menopause symptoms, hormone therapy (HT) is also known to provide multiple health benefits, including slowing the progression of atherosclerosis. A study based on Early Versus Late Intervention Trial With Estradiol (ELITE) data evaluated the underlying mechanism of such benefit and will be presented during the […]
  • Newer Type 2 diabetes medications have heart and kidney disease benefits, too September 28, 2020
    Two newer classes of medications used to treat Type 2 diabetes have been shown to protect patients against heart disease and chronic kidney disease, in addition to their ability to help manage blood glucose. Patients with Type 2 diabetes have a high rate of chronic kidney and cardiovascular disease and more serious complications; these newer […]
  • Cannabis use for menopause symptom management September 28, 2020
    CLEVELAND, Ohio (September 28, 2020)--As legislation relaxes regarding cannabis, it is being used to manage numerous chronic health conditions and mood symptoms. A new study indicates that a growing number of women are either using cannabis or want to use it for the management of bothersome menopause symptoms. Study results will be presented during the […]
  • Advances in nonhormone therapies provide women with more options for managing hot flashes September 28, 2020
    Although many women manage menopause symptoms with hormone therapy, increasing numbers of women are considering nonhormone options. Dr. Susan Reed from the University of Washington School of Medicine is a featured speaker during the 2020 Pre-Meeting Symposium of The North American Menopause Society (NAMS) and will discuss the latest advances in nonhormone hot flash management. […]
  • 1 in 3 parents plan to skip flu shots for their kids during COVID-19 pandemic September 28, 2020
    The pandemic doesn't seem to be changing parents' minds about the importance of the flu vaccine.
Top